Neogen 8-K 2012
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Pursuant to Section 13 OR 15(d) of The
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) May 1, 2012
(Exact name of registrant as specified in its charter)
Registrants telephone number, including area code 517-372-9200
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Item 2.01. Completion of Acquisition or Disposition of Assets
On May 1, 2012 Neogen Corporation issued a press release announcing that it had acquired the assets of the Igenity animal genomics business from Merial Limited. Igenity had been a significant customer of Neogens Geneseek business unit.
Neogen intends to move the business to its Geneseek unit in Lincoln, Nebraska, which reports within Neogens Animal Safety segment.
A copy of the press release is attached as Exhibit 99.1 to this report.
(a) Financial statements and pro forma financial statements of the business acquired are inapplicable and, therefore, have been omitted.
(b) Exhibit 99.1Press Release dated May 1, 2012 announcing Neogen Corporations acquisition of the assets of the Igenity animal genomics business from Merial.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.